Stay updated with breaking news from Vstm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mizuho initiated coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research report issued on Wednesday, The Fly reports. The brokerage set a “neutral” rating on the biopharmaceutical company’s stock. Several other equities analysts also recently issued reports on the stock. HC Wainwright reaffirmed a “buy” rating and set a $3.00 price target […]
Verastem, Inc. (NASDAQ:VSTM – Get Rating) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 1,620,000 shares, an increase of 39.7% from the February 28th total of 1,160,000 shares. Based on an average trading volume of 788,100 shares, the days-to-cover ratio is currently […]
StockNews.com began coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other analysts also recently issued reports on VSTM. HC Wainwright reissued a buy rating and issued a $3.00 target price on shares of […]
Stock analysts at Mizuho started coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note issued to investors on Wednesday, The Fly reports. The brokerage set a “neutral” rating on the biopharmaceutical company’s stock. Several other research firms have also commented on VSTM. HC Wainwright reiterated a “buy” rating and issued a […]
Verastem (NASDAQ:VSTM – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Friday, Zacks.com reports. According to Zacks, “Verastem, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing drugs to improve outcomes for patients with cancer. Its programs target the focal […]